Dr. Haitao Zhu, PhD, was a partner at SVE Partners, an early stage venture fund where her focus was on biotech and medical device investments. Prior to that, Haitao was Group Leader at Genentech in the Neurodevelopment area.
Dr Zhu has previously led investments and served as board observer in Mesa Diagnostics (acquired by Thermo-Fisher) and SetPoint Medical (with investments from NEA).
Acquired by Thermo Fisher
SPAC, March 2022